NEW

Canon Medical Announces New Aquilion Exceed LB CT System

An estimated 1.8 million new cancer cases will be diagnosed in the U.S. this year alone, according to the American Cancer Society. With a disease so prevalent, treatments like radiation therapy are critical, and while planning, clinicians require accuracy, precision...

Bracco Diagnostics Inc. Introduces New CardioGen-82 Infusion System

Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., has announced the FDA approval of its new CardioGen-82 infusion system to enhance automation, efficiency and simplicity in cardiac position emission tomography (PET) myocardial perfusion imaging...

Health Network Places $11 Million Order

GE Healthcare has announced its largest ever ultrasound deal in the United States – an $11 million order by St. Luke’s University Health Network to install GE Healthcare ultrasound technology and IT workflow solutions system-wide. GE Healthcare will continue upgrades...

Aidoc Granted AI Industry-First FDA Clearance for Triage of Incidental Pulmonary Embolism

Aidoc has announced that the U.S. Food and Drug Administration (FDA) has given regulatory clearance for the commercial use of its triaging and notification algorithms for flagging and communicating incidental pulmonary embolism. Flagging incidental, critical findings...

Hologic Updates Brevera Breast Biopsy System with CorLumina Imaging Technology

Hologic Inc. has announced improvements to the Brevera® Breast Biopsy System with CorLumina® Imaging Technology, the world’s first and only breast biopsy solution to combine vacuum-assisted tissue acquisition, real-time imaging verification and advanced post-biopsy handling in one, integrated system.

Since its launch in 2017, the Brevera system has shifted the way clinicians perform breast biopsies and verify that the targeted tissue samples have been acquired. The system streamlines the entire biopsy process from start to finish – with real-time imaging for verification of sample acquisition and automated post-biopsy specimen handling. These integrated features offer the potential to save facilities an average of 13 minutes per procedure to transform the patient experience and enhance workflow. In addition, they allow clinicians to remain by the patient’s side during the entire procedure, eliminating the need to leave the room to image and verify tissue samples, which often leads to lengthy procedure times and anxious patients, as well as interruptions to facility screening schedules.

“As a world leader in breast health, we take great pride in our commitment to constant innovation – informed by clinical research and customer feedback – to continuously expand and improve upon the performance of our products,” said Jennifer Meade, Hologic’s Division President, Breast and Skeletal Health Solutions. “The launch of the Brevera system represented a major transformation in breast biopsy, and we’re confident that the improvements we’ve introduced will further the system’s ability to enhance workflow, increase accuracy and improve the overall patient experience.”

To better meet clinician needs, the Brevera system features a reusable device driver and disposable needles to simplify storage and improve waste management. The system also features improvements that allow radiologists and technologists to better separate and verify target samples automatically, then transfer seamlessly to pathology with minimal handling to help maintain core integrity.

The Brevera system is designed for use with Hologic’s Affirm Prone biopsy guidance system. When paired together, the Brevera system and Affirm system accelerate the speed and efficiency of prone biopsy procedures to further reduce the patient’s time under compression.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *